Alternative Systemic Treatments for Vitiligo: A Review

[1]  Hong-Duo Chen,et al.  Treatment of vitiligo with NB-UVB: A systematic review , 2015, The Journal of dermatological treatment.

[2]  Nura El-Haj,et al.  Sun protection in a pill: the photoprotective properties of Polypodium leucotomos extract , 2015, International journal of dermatology.

[3]  N. Sadick,et al.  Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders. , 2014, The Journal of clinical and aesthetic dermatology.

[4]  D. Ertuğrul,et al.  Serum holotranscobalamine, vitamin B12, folic acid and homocysteine levels in patients with vitiligo , 2012, Clinical and experimental dermatology.

[5]  N. Bagherani,et al.  HYPOTHESIS: ZINC CAN BE EFFECTIVE IN TREATMENT OF VITILIGO , 2011, Indian journal of dermatology.

[6]  R. Spritz.  Recent progress in the genetics of generalized vitiligo. , 2011, Journal of genetics and genomics = Yi chuan xue bao.

[7]  N. Bagherani,et al.  Vitiligo: A review of the published work , 2011, The Journal of dermatology.

[8]  N. Bagherani,et al.  Original article title: "Comparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a clinical trial" , 2011, BMC dermatology.

[9]  H. Boon,et al.  Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial , 2011, BMC complementary and alternative medicine.

[10]  Á. Juarranz,et al.  Current Trends in Photoprotection - A New Generation of Oral Photoprotectors , 2011 .

[11]  J. Silverberg,et al.  Serum homocysteine as a biomarker of vitiligo vulgaris severity: a pilot study. , 2011, Journal of American Academy of Dermatology.

[12]  P. Bjerring,et al.  Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation , 2011, Journal of the European Academy of Dermatology and Venereology.

[13]  R. Spritz.  Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease. , 2010, Thyroid : official journal of the American Thyroid Association.

[14]  D. Schmitt,et al.  Gingko biloba extract reduces VEGF and CXCL-8/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate , 2010, Archives of Dermatological Research.

[15]  M. Elgoweini,et al.  Response of Vitiligo to Narrowband Ultraviolet B and Oral Antioxidants , 2009, Journal of clinical pharmacology.

[16]  T. Jouary,et al.  Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre , 2009, The British journal of dermatology.

[17]  Vinod K. Sharma,et al.  Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo , 2009, Archives of Dermatological Research.

[18]  M. Picardo,et al.  Clinical practice. Vitiligo. , 2009, The New England journal of medicine.

[19]  O. Shaker,et al.  Is there a relationship between homocysteine and vitiligo? A pilot study , 2008, The British journal of dermatology.

[20]  H. Boon,et al.  A systematic review of natural health product treatment for vitiligo , 2008, BMC dermatology.

[21]  S. Moretti,et al.  Vitiligo: new and emerging treatments , 2008, Dermatologic therapy.

[22]  M. Picardo,et al.  Antioxidants and narrow band‐UVB in the treatment of vitiligo: a double‐blind placebo controlled trial , 2007, Clinical and experimental dermatology.

[23]  F. Rius-Díaz,et al.  Treatment of vitiligo vulgaris with narrow‐band UVB and oral Polypodium leucotomos extract: a randomized double‐blind placebo‐controlled study , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[24]  N. Scheinfeld,et al.  A review of DNA repair and possible DNA-repair adjuvants and selected natural anti-oxidants. , 2007, Dermatology online journal.

[25]  Susan M. Schlenner,et al.  Kit is essential for PMA-inflammation-induced mast-cell accumulation in the skin. , 2007, Blood.

[26]  S. González,et al.  Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: A pilot study. , 2006, Journal of dermatological science.

[27]  Aurel O. Iuga,et al.  Treatment of vitiligo with broadband ultraviolet B and vitamins , 2006, International journal of dermatology.

[28]  J. Wood,et al.  Decreased phenylalanine uptake and turnover in patients with vitiligo. , 2005, Molecular genetics and metabolism.

[29]  Amy Padula,et al.  Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature. , 2005, Journal of general internal medicine.

[30]  A. Avins,et al.  Spontaneous bleeding associated with Ginkgo biloba , 2005, Journal of General Internal Medicine.

[31]  P. Prasad,et al.  Serum zinc level in vitiligo: a case control study. , 2005, Indian journal of dermatology, venereology and leprology.

[32]  M. Mihm,et al.  Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skin. , 2004, Journal of American Academy of Dermatology.

[33]  F. Egli,et al.  Images in clinical medicine. Vitiligo and pernicious anemia. , 2004, The New England journal of medicine.

[34]  P. Christova,et al.  Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA , 2004, Clinical and experimental dermatology.

[35]  S. Dogra,et al.  Health and Quality of Life Outcomes , 2003 .

[36]  F. Camacho,et al.  Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo. , 2002, Journal of drugs in dermatology : JDD.

[37]  V. K. Çelık,et al.  The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA. , 2002, European journal of dermatology : EJD.

[38]  J. P. Pivel,et al.  Immunomodulatory properties of a hydrophilic extract of Polypodium leucotomos , 2001, InflammoPharmacology.

[39]  H. Kerl,et al.  Long-term results in the treatment of vitiligo with oral khellin plus UVA. , 2001, European journal of dermatology : EJD.

[40]  F. Camacho,et al.  Treatment of vitiligo with oral and topical phenylalanine: 6 years of experience. , 1999, Archives of dermatology.

[41]  S. Passi,et al.  Epidermal oxidative stress in vitiligo. , 1998, Pigment cell research.

[42]  J. Sawatzki,et al.  In vivo evidence for compromised phenylalanine metabolism in vitiligo. , 1998, Biochemical and biophysical research communications.

[43]  L. Juhlin,et al.  Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. , 1997, Acta dermato-venereologica.

[44]  S. Hann,et al.  Clinical features of vitiligo. , 1997, Clinics in dermatology.

[45]  F. Ochsendorf,et al.  Vitiligo treatment with phenylalanin/UV A. Follow-up studies after 5 years , 1994 .

[46]  L. Montes,et al.  Folic acid and vitamin B12 in vitiligo: a nutritional approach. , 1992, Cutis.

[47]  C. Antoniou,et al.  Phenylalanine plus Ultraviolet Light: Preliminary Report of a Promising Treatment for Childhood Vitiligo , 1989, Pediatric dermatology.

[48]  A. Katsambas,et al.  Vitiligo Therapy with Oral and Topical Phenylalanine with UVA Exposure , 1989, International journal of dermatology.

[49]  A. Mohammad.  Vitiligo repigmentation with Anapsos (Polypodium leucotomos) , 1989, International journal of dermatology.

[50]  H. Hönigsmann,et al.  Phototherapeutic, photobiologic, and photosensitizing properties of khellin. , 1988, The Journal of investigative dermatology.

[51]  H. Hönigsmann,et al.  Treatment of vitiligo with khellin and ultraviolet A. , 1988, Journal of the American Academy of Dermatology.

[52]  G. Steigleder,et al.  [Repigmentation treatment of vitiligo with L-phenylalanine and UVA irradiation]. , 1987, Zeitschrift fur Hautkrankheiten.

[53]  Cormane Rh,et al.  Oral phenylalanine loading and sunlight as source of UVA irradiation in vitiligo on the Caribbean island of Curacao NA. , 1986 .

[54]  B. El-menshawi,et al.  An approach to the treatment of vitiligo by khellin. , 1982, Dermatologica.

[55]  M. Schwartz,et al.  Vitiligo, achlorhydria, and pernicious anaemia. , 1971, Lancet.

[56]  W. Ryan,et al.  Inhibition of Antibody Synthesis by L�Phenylalanine , 1964, Science.

[57]  R. Baggott.  DISEASE , 1947, Social Policy & Administration.

[58]  J. Sabry,et al.  Serum levels of homocysteine, vitamin B12, and folic acid in vitiligo , 2014 .

[59]  S. Singh,et al.  Increased level of serum Homocysteine in vitiligo , 2011, Journal of clinical laboratory analysis.

[60]  D. Bandyopadhyay,et al.  Indian J Dermatol Venereol Leprol , 2010 .

[61]  W. Westerhof,et al.  Phenylalanine and UVA light for the treatment of vitiligo , 2004, Archives of Dermatological Research.

[62]  L Juhlin,et al.  Treatment of vitiligo vulgaris with narrow band UVB (311 nm) for one year and the effect of addition of folic acid and vitamin B12. , 2002, Acta dermato-venereologica.

[63]  F. Ochsendorf,et al.  [Vitiligo therapy with phenylalanine/UV A. Catamnestic studies after five years]. , 1994, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[64]  W. Westerhof,et al.  L-phenylalanine and UVA irradiation in the treatment of vitiligo. , 1994, Dermatology.

[65]  R. Cormane,et al.  Oral phenylalanine loading and sunlight as source of UVA irradiation in vitiligo on the Caribbean island of Curacao NA. , 1986, The Journal of tropical medicine and hygiene.